The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

Gilead’s HIV treatment trials involving GS-1720 and GS-4182 have been put on clinical hold by the Food and Drug Administration.

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

Kennedy said that Pallone had previously been a champion of people who had been harmed by vaccines and only changed his tune ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

A twice-a-year shot to prevent HIV being dubbed a "wonder drug" by some could be coming to Canada as soon as next year, ...

The FDA has approved a revolutionary, long-acting injectable that could change the way HIV is prevented. The treatment is just two shots a year, and has proven to be nearly 100% effective in clinical ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

The U.S. has approved the world's only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...